Valneva SE banner

Intrinsic Value

The intrinsic value of Valneva SE (VLA) under the Base Case is 1.302 EUR per share. Compared with the current market price of 2.453 EUR, the stock appears Overvalued by 47% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

VLA Intrinsic Value
€1.302
Overvaluation 47%
Intrinsic Value
Price €2.453

VLA is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor VLA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €1.04
Get notified when the price drops into your buy zone
Current Price €2.45
Intrinsic Value €1.3
Margin of Safety 20% €1.04
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to VLA

Fundamental Analysis

What Valneva Does

Biotechnology Health Care

Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.

Headquarters
France FR
Employees
674
IPO date
Jun 28, 2007
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Valneva SE

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

VLA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VLA stock?

The intrinsic value for Valneva SE (VLA) under the Base Case is 1.302 EUR.

Is VLA stock undervalued or overvalued?

Compared with the current market price of 2.453 EUR, the stock appears Overvalued by 47% .

Back to Top